[1]刘彤崴,田 蕾,任恒杰,等.胃癌中微小RNA-424-5p与真核翻译起始因子5A的表达特征研究[J].陕西医学杂志,2023,52(4):472-475.[doi:DOI:10.3969/j.issn.1000-7377.2023.04.025]
点击复制

胃癌中微小RNA-424-5p与真核翻译起始因子5A的表达特征研究
分享到:

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
52
期数:
2023年4期
页码:
472-475
栏目:
临床病理
出版日期:
2023-04-05

文章信息/Info

作者:
刘彤崴田 蕾任恒杰周 盾王 莹
(锦州医科大学附属第一医院,辽宁 锦州 121000)
关键词:
胃癌 微小RNA-424-5p 真核翻译起始因子5A 靶向关系 预后
分类号:
R 735.2
DOI:
DOI:10.3969/j.issn.1000-7377.2023.04.025
文献标志码:
A
摘要:
目的:观察胃癌中微小RNA-424-5p(miR-424-5p)与真核翻译起始因子5A(eIF5A)的表达特征,分析二者的靶向关系。方法:收集确诊为胃癌并行根治术的患者共65例作为研究对象,留取肿瘤组织和正常胃黏膜组织,应用实时荧光定量PCR法(qPCR)检测miR-424-5p的表达,应用免疫组化法检测eIF5A的表达。选择胃癌MGC-803细胞株,应用双荧光素酶报告基因实验观察miR-424-5p与eIF5A的结合情况。结果:胃癌中miR-424-5p的表达量明显低于正常胃黏膜组织(P<0.05),eIF5A的阳性率明显高于正常胃黏膜组织(P<0.05),miR-424-5p与eIF5A在不同肿瘤最大径、不同浸润深度、有无淋巴结转移分组的比较中有统计学差异(P<0.05)。miR-424-5p与eIF5A呈负相关性(Y=-2.572X+7.662,P<0.05)。miR-424-5p和eIF5A的表达与术后生存时间相关(均P<0.05)。双荧光素酶报告基因实验显示miR-424-5p与eIF5A具有靶向关系。结论:胃癌组织中miR-424-5p表达下调、eIF5A表达升高,且具有靶向负调控关系。miR-424-5p和eIF5A的表达可能与患者术后生存时间有关。

参考文献/References:

[1] 张 俊,张丽秋,姜登鸽,等.微小RNA-141和Yes相关蛋白1在胃癌组织中的表达及其对胃癌SGC-7901细胞增殖的影响[J].陕西医学杂志,2022,51(3):280-283.
[2] 张鹏飞,刘新奇,石 菲.miR-35对胃癌细胞MNK-45凋亡的作用及机制探讨[J].陕西医学杂志,2022,51(2):239-244.
[3] Teng F,Zhang JX,Chang QM,et al.LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma[J].J Exp Clin Cancer Res,2020,39(1):235-237.
[4] Cui Y,Yang J,Bai Y,et al.MiR-424-5p regulates cell proliferation and migration of esophageal squamous cell carcinoma by targeting SIRT4[J].J Cancer,2020,11(21):6337-6347.
[5] 卓少华,丘远聪,郑俊德,等.人参皂苷Rg5调控lncRNA-PCAT12抑制胃癌细胞生长实验研究[J].陕西中医,2020,41(4):437-439.
[6] Bencsik P,Kiss K,Agg B,et al.Sensory neuropathy affects cardiac mirna expression network targeting IGF-1,SLC2a-12,EIF-4e,and ULK-2 mRNAs[J].Int J Mol Sci,2019,20(4):991-993.
[7] Ning L,Wang L,Zhang H,et al.Eukaryotic translation initiation factor 5A in the pathogenesis of cancers[J].Oncol Lett,2020,20(4):81-83.
[8] 杨 茜,叶冬雪,马晏然,等.EIF5A2在人肝细胞癌中的表达及其与术后生存期的关系[J].肿瘤防治研究,2021,48(6):617-624.
[9] 王 莉.卵巢浆液性癌组织中起始因子EIF5A_2和基质金属蛋白酶-21的表达及临床意义[J].陕西医学杂志,2020,49(4):411-414.
[10] 周 婺,王俊杰.EIF5A2基因在恶性肿瘤中的研究进展[J].肿瘤,2018,38(3):270-277.
[11] Li Y,Liu J,Hu W,et al.MiR-424-5p Promotes proliferation,migration and invasion of laryngeal squamous cell carcinoma[J].Onco Targets Ther,2019,12:10441-10453.
[12] Zhao Y,Zhu C,Chang Q,et al.MiR-424-5p regulates cell cycle and inhibits proliferation of hepatocellular carcinoma cells by targeting E2F7[J].PLoS One,2020,15(11):e0242179.
[13] Li L,Li X,Zhang Q,et al.EIF5A expression and its role as a potential diagnostic biomarker in hepatocellular carcinoma[J].J Cancer,2021,12(16):4774-4779.
[14] Liu X,Niu N,Li P,et al.LncRNA OGFRP1 acts as an oncogene in NSCLC via miR-4640-5p/eIF5A axis[J].Cancer Cell Int,2021,21(1):425.
[15] Liu Z,Teng L,Gao L,et al.The role of eukaryotic translation initiation factor 5A-1(eIF5A-1)gene in HPV 16 E6 induces cell growth in human cervical squamous carcinoma cells[J].Biochem Biophys Res Commun,2018,504(1):6-12.
[16] 陈杰伟,陈克明,蔡小嘉,等.食管癌中真核翻译起始因子5A2的表达及与预后的相关性[J].中山大学学报:医学科学版,2017,38(4):512-516.
[17] Bao Y,Lu Y,Wang X,et al.Eukaryotic translation initiation factor 5A2(eIF5A2)regulates chemoresistance in colorectal cancer through epithelial mesenchymal transition[J].Cancer Cell Int,2015,15:109.
[18] 刘爱东,刘时飞,熊光宜,等.真核翻译起始因子2α促进结直肠腺癌细胞增殖[J].中华实验外科杂志,2022,39(9):1752-1754.
[19] Wang Z,Jiang J,Qin T,et al.EIF5A regulates proliferation and chemoresistance in pancreatic cancer through the sHH signalling pathway[J].J Cell Mol Med,2019,23(4):2678-2688.
[20] Liu W,Che J,Gu Y,et al.Silencing of lncRNA SNHG12 inhibits proliferation and migration of vascular smooth muscle cells via targeting miR-766-5p/EIF5A axis[J].Adv Clin Exp Med,2021,30(6):591-598.

相似文献/References:

[1]侯洁心 ,郭萍△.免疫组化标志物Her2和肿瘤标志物在胃癌诊断中的价值分析*[J].陕西医学杂志,2019,(1):121.
 HOU Jiexin,GUO Ping..The value of immunohistochemical marker Her2 andtumor markers in the diagnosis of gastric cancer[J].,2019,(4):121.
[2]唐亚荣.循环热灌注化疗联合替吉奥及热疗治疗老年胃癌癌性腹水临床研究*[J].陕西医学杂志,2019,(4):435.
 TANG Yarong..Clinical effect analysis of combined therapy with tiago and hyperthermia in the treatment of malignant ascites in elderly patients with gastric cancer[J].,2019,(4):435.
[3]刘国庆,闫 龙△,高 任.1.5T磁共振扩散加权成像在胃癌淋巴结转移诊断中的应用价值*[J].陕西医学杂志,2019,(4):456.
 LIU Guoqing,YAN Long,GAO Ren..1.5T magnetic resonance diffusion weighted imaging in the diagnosis of lymph node metastasis of gastric cancer[J].,2019,(4):456.
[4]胡乃军,王海龙.胃腺癌组织中MMP11、MMP12和VEGFD的表达及临床意义[J].陕西医学杂志,2019,(5):554.
[5]米志宽,赵菊梅.抑癌基因甲基化与胃癌关系研究进展*[J].陕西医学杂志,2019,(5):679.
 MI Zhikuan,ZHAO Jumei..Research progress of relationships between tumor suppressor gene methylation and gastric cancer[J].,2019,(4):679.
[6]石颖鹏,王敏娟,李程亮.肠化生相关分子与胃癌的发生和进展研究概况[J].陕西医学杂志,2019,(7):958.
 SHI Yingpeng,WANG Minjuan,LI Chengliang,et al.Intestinal metaplasia-related molecules and the occurrence and progress of gastric cancer[J].,2019,(4):958.
[7]郭小艳,于桂萍.抗幽门螺杆菌疗法联合新辅助化疗对胃癌术后疗效及患者血清VEGF、bFGF的影响[J].陕西医学杂志,2019,(8):1010.
 GUO Xiaoyan,YU Guiping..Effect of anti-Helicobacter pylori therapy combined with neoadjuvant chemotherapy on serum VEGF and bFGF in postoperative patients with gastric cancer[J].,2019,(4):1010.
[8]柯东平,毛俊倩,郭甲民,等.SCNN1B与胃癌细胞上皮间质转化相关性实验研究*[J].陕西医学杂志,2019,(9):1115.
 KE Dongping,MAO Junqian,GUO Jiamin,et al.Research on the correlation between SCNN1B and〖JZ〗 epithelialmesenchymal transformation in gastric cancer cells[J].,2019,(4):1115.
[9]王小林,马任远,张 哲.腹腔镜手术治疗老年进展期胃癌50例临床疗效分析[J].陕西医学杂志,2019,(10):1360.
[10]刘维帅,郭晓宁,杨 洋,等.胃癌病理类型及临床预后与血清miR-133a和DKK-1相关性分析[J].陕西医学杂志,2020,49(6):751.[doi:DOI:10.3969/j.issn.10007377.2020.06.028]
 LIU Weishuai,GUO Xiaoning,YANG Yang,et al.Correlation of pathological types and clinical prognosis of gastric cancer with serum miR-133a and DKK-1[J].,2020,49(4):751.[doi:DOI:10.3969/j.issn.10007377.2020.06.028]

备注/Memo

备注/Memo:
基金项目:辽宁省教育厅科学技术研究项目(JYTJCZR 2020052)
更新日期/Last Update: 2023-04-06